AptaMol Technologies is an early‑stage deep‑tech biosciences venture developing state-of-the-art molecular platforms to power next‑generation research, healthcare innovation, environmental surveillance, and point‑of‑care diagnostic solutions. We build robust, tunable, and highly specific sensing systems integrated with uniquely engineered devices to support unmet biodetection requirements across biomedical and environmental domains.
As scientific validation and prototype development progress, AptaMol operates in a structured, limited‑disclosure mode. Our current innovation portfolio spans neonatal screening, AMR surveillance, infection detection and cancer diagnosis.
We build comprehensive molecular detection tools and integrate with innovative engineering solutions to enable precision, stability, and reproducible molecular diagnostics that address the growing need for rapid, accessible, and reliable molecular detection.
Email: contact@aptamol.com
Location: India